361 results on '"Blum, Mariela A."'
Search Results
52. Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States
53. Relationship between initial management strategy and survival in patients with gastric outlet obstruction due to gastric cancer
54. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience
55. Abstract B06: A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries
56. Preoperative Therapy Regimen Influences the Incidence and Implication of Nodal Downstaging in Patients with Gastric Cancer
57. Linitis Plastica: a Distinct Type of Gastric Cancer
58. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer
59. Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer
60. Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer
61. Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma
62. Abstract 3859: Targeting CDK9 and MCL-1 by a New CDK9/p-TEFB Inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma
63. Su1163 ENDOSCOPIC ULTRASOUND GUIDED TISSUE ACQUISITION FOR GASTRIC CANCER DIAGNOSTIC PROFILING AS AN ADJUNCT TO ENDOSCOPIC MUCOSAL BIOPSIES
64. Phase I trial of hyperthermic intraperitoneal chemoperfusion (HIPEC) with cisplatin, mitomycin, and paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology.
65. 217 – Characteristics and Survival of Gastric Cancer Patients with Pathological Complete Response
66. Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?
67. Tumor regression grade in gastric cancer after preoperative therapy.
68. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries
69. Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma
70. Repeat staging laparoscopy for gastric cancer after preoperative therapy
71. Targeting cyclin-dependent kinase 9 enhances sensitization to ionizing radiation in esophageal adenocarcinoma and identifies AXL as a novel downstream target
72. Abstract A055: RSPO3 overexpression is a characteristic feature of signet ring gastrointestinal malignancies
73. Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort
74. Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
75. Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonography
76. Preoperative Chemoradiation Therapy Does Not Increase Risk of Anastomotic Leak in Patients With Gastric Cancer
77. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis
78. Targeting cyclin-dependent kinase 9 enhances sensitization to ionizing radiation in esophageal adenocarcinoma and identifies AXL as a novel downstream target
79. Adjuvant chemotherapy following trimodality therapy for esophageal carcinoma—Is the evidence sufficient?
80. Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy
81. Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma
82. Phase 1 dose escalation of ZW25, a HER2-targeted bispecific antibody, in patients (pts) with HER2-expressing cancers.
83. Left Gastric Artery Lymph Nodes Should be Included in D1 Lymph Node Dissection in Gastric Cancer
84. Preoperative Chemoradiation Therapy Does not Increase Risk of Anastomotic Leak in Gastric Cancer Patients
85. It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma
86. 18F-FDG PET/CT as Predictive of Response after Chemoradiation in Esophageal Cancer Patients
87. Personalised therapy for localised gastric and gastro-oesophageal adenocarcinoma
88. Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer
89. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience
90. Survival rates in T1 and T2 gastric cancer: A Western report
91. Continuation of trastuzumab beyond disease progression in patients with metastatic gastric cancer: A retrospective analysis of 25 cases—The MD Anderson experience.
92. Outcomes in older patients with localized gastric adenocarcinoma treated preoperatively.
93. Influence of induction chemotherapy (IC) in trimodality-eligible esophageal cancer patients: Secondary analysis of a randomized trial.
94. Risk factors for survival in early T stage gastric cancer.
95. A phase II study of laparoscopic hyperthermic intraperitoneal chemoperfusion (HIPEC) for gastric carcinomatosis or positive cytology.
96. Correlation of pretreatment p63-positive subtype of gastroesophageal adenocarcinoma (GEAC) with pathologic complete response (pathCR) in patients receiving preoperative chemoradiation.
97. Preoperative accuracy of gastric cancer staging in patient selection for neoadjuvant therapy.
98. Staging laparoscopy with cytology analysis in gastric cancer.
99. Course and predictors of postoperative outcomes in older patients with localized gastric adenocarcinoma treated preoperatively.
100. A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.